NBSE - Symetryx exits stake in NeuBase Therapeutics shares fall
2023-09-19 14:03:39 ET
- NeuBase Therapeutics ( NASDAQ: NBSE ) falls 14% after disclosing that Symetryx has sold its entire position in the biopharmaceutical company.
- Symetryx sold 203,337 shares in the price range of $1.19-$1.44. Symetryx has sold 680,081 shares in the last 10 days.
- According to the form 4 , Symetryx now beneficially owns no shares in the company.
- As per the recent filing on Sept. 06, Symetryx acquired 20% stake in NeuBase.
For further details see:
Symetryx exits stake in NeuBase Therapeutics, shares fall